Loading content...
LEVOTHYROXINE SODIUM
Wed Oct 15 2025
0 views
Reason for Recall
Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.
Manufacturers
| Drug | Manufacturer |
|---|---|
| LEVOTHYROXINE SODIUM | Accord Healthcare Inc. |
Number of affected units
54,432 bottles
Distribution pattern
Nationwide in the US
UPCs
| UPC |
|---|
| 0316729447157 |
| 0316729449151 |
| 0316729452151 |
| 0316729454155 |
| 0316729453158 |
| 0316729448154 |
| 0316729451154 |
| 0316729457156 |
| 0316729450157 |
| 0316729456159 |
| 0316729458153 |
| 0316729455152 |
Package NDCs
| NDC |
|---|
| 16729-458-15 |
| 16729-458-17 |
| 16729-447-15 |
| 16729-447-17 |
| 16729-448-15 |
| 16729-448-17 |
| 16729-449-15 |
| 16729-449-17 |
| 16729-451-15 |
| 16729-451-17 |
| 16729-450-15 |
| 16729-450-17 |
| 16729-452-15 |
| 16729-452-17 |
| 16729-453-15 |
| 16729-453-17 |
| 16729-454-15 |
| 16729-454-17 |
| 16729-455-15 |
| 16729-455-17 |
| 16729-456-15 |
| 16729-456-17 |
| 16729-457-15 |
| 16729-457-17 |
Comments (-)
Must be signed in to post a comment.